Delivery Order SPE2DR25D3101-SPE2DR26F5P37
- Not listed
- The Defense Logistics Agency awarded a $10,274.35 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count). The contract utilizes firm fixed-price terms and is classified as a non-competitive, non-set-aside award. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of NURTEC ODT 75 mg tablets (8-pack quantity) valued at $14,310.29 under a firm fixed price contract. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a $2,869.43 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on October 31, 2025, with completion targeted for November 3, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a $6,406.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count package), with a completion date of November 14, 2025. This non-set-aside contract award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $13,614.27 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on December 10, 2025, with completion scheduled for December 11, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The award will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $17,461.79 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed price contract type. This non-competitive delivery order was issued on June 16, 2025, with an ultimate completion date of June 17, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $107,953.28 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under firm fixed price terms. This non-competitive delivery order, issued on October 30, 2025, with completion expected by October 31, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $34,325.27 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count package) with a firm fixed price structure. This non-competitive delivery order was awarded on November 18, 2025, with an ultimate completion date of November 19, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,501.91 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packages) on December 10, 2025, with completion expected by December 11, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5P37Delivery Order
The Defense Logistics Agency awarded a $15,680.90 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of November 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities to support federal medical procurement needs. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent success in meeting competitive procurement requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The delivery of NURTEC ODT, a migraine treatment medication, supports the broader defense health mission by ensuring pharmaceutical availability for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 11/23/25 |